Invention Grant
- Patent Title: Heterocyclic LSF inhibitors and their uses
-
Application No.: US17155547Application Date: 2021-01-22
-
Publication No.: US11242353B2Publication Date: 2022-02-08
- Inventor: Scott E. Schaus , Ulla Hansen , John A. Kavouris , Emily A. York , Niranjana Pokharel
- Applicant: TRUSTEES OF BOSTON UNIVERSITY
- Applicant Address: US MA Boston
- Assignee: TRUSTEES OF BOSTON UNIVERSITY
- Current Assignee: TRUSTEES OF BOSTON UNIVERSITY
- Current Assignee Address: US MA Boston
- Agency: Nixon Peabody LLP
- Agent Ronald Eisenstein; Ravinderjit Braich
- Main IPC: C07D491/056
- IPC: C07D491/056 ; A61P35/00
Abstract:
The present invention is directed to heterocyclic SV40 Factor (LSF) inhibitors and their uses. In some implementations, the present invention discloses small-molecule compounds of Formula (I). In some implementations, the compounds of Formula (I) are used in methods for inhibiting LSF in a subject. In some implementations, the compounds of Formula (I) are used in methods for treating cancer in a subject.
Public/Granted literature
- US20210230173A1 HETEROCYCLIC LSF INHIBITORS AND THEIR USES Public/Granted day:2021-07-29
Information query
